Partner Interview
Published September 4, 2021
Illumina & Gene Sequencing
inpractise.com/articles/illumina-and-gene-sequencing
Executive Bio
General Manager, QIAGEN Waltham
Why is this interview interesting?
- The history and evolution of next generation sequencing
- Durability of ILMN’s SBS platform advantage vs long read PACB
- History of proteomics and how the industry may evolve
Interview Transcript
Disclaimer: This interview is for informational purposes only and should not be relied upon as a basis for investment decisions. In Practise is an independent publisher and all opinions expressed by guests are solely their own opinions and do not reflect the opinion of In Practise.
Free Sample of 50+ Interviews
Sign up to test our content quality with a free sample of 50+ interviews.
Or contact sales for full access
Related Content
Bio-Rad: Switching Costs and Competitive Dynamics in Single-Cell & Digital PCR
Former Director at Bio-Rad Laboratories
Vitrolife: Genetic Testing Lab Operations
Former Senior Scientific Executive at Igenomix
10x Genomics: Visium, NanoString Tech & Future of Single-Cell Analysis
Former Sales Manager at 10x Genomics
Weekly Update: Ashtead & Equipment Rental: A More Resilient Business
© 2024 In Practise. All rights reserved. This material is for informational purposes only and should not be considered as investment advice.